Certara launches TFL Studio to accelerate scientific workflows
The new TFL Studio module within Certara’s Phoenix® Cloud platform automates time-consuming data presentation tasks.
Certara (PA, USA), a global leader in model-informed drug development, has unveiled TFL Studio, the first cloud-native module in its Phoenix Cloud platform. Designed for pharmacokinetic (PK) and pharmacodynamic (PD) scientists, TFL Studio automates the creation of Tables, Figures and Listings (TFLs), which are key components in regulatory submissions and scientific publications, cutting production time by up to 50%.
TFLs are vital for presenting study data in clear, regulatory-compliant formats, yet traditional workflows are often slowed by fragmented tools and manual editing. Certara’s cloud-based approach aims to modernize this process, improving both efficiency and consistency across studies.
You may also be interested in:
- How blockchain and AI are transforming data integrity in bioanalysis
- Nathan Teuscher on how Aplos Analytics is transforming the PK analysis landscape
- The use of GenAI in bioanalysis: an interview with Priyata Kalra
TFL Studio provides a user-friendly, no-code interface that allows scientists to build standardized, reusable templates, generate dynamic outputs and easily refine visualizations, all without complex coding or data transfers.
The launch also prepares the stage for AI PK Reports, a complementary module powered by CoAuthorTM, Certara’s generative AI software. Expected to be released later this quarter, it will automatically convert TFLs into draft PK reports in minutes rather than days.
“TFL Studio empowers scientists to create high-quality TFLs up to 50% faster, freeing them from the technical complexities of moving source data, coding and manual formatting,” commented Martin Snyder, President of Certara Data Sciences. “This allows them to focus on science, derive insights more quickly and ultimately accelerate critical decision-making.”
